Ametek, Inc. (AME) Misses Q2 EPS by 19c; Guides FY12

Ametek, Inc. (NYSE: AME) reported Q2 EPS of $0.27, $0.19 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $825.9 million versus the consensus estimate of $861.54 million.

Ametek, Inc. sees FY2012 EPS of $1.83-$1.85, versus the consensus of $1.85.

For earnings history and earnings-related data on Ametek, Inc. (AME) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
• Bragg Gaming Group Inc. (BRAG) Tops Q2 EPS by 2c